Multicyclic compounds and methods of use thereof

Details for Australian Patent Application No. 2010325925 (hide)

Owner Sunovion Pharmaceuticals, Inc. Psychogenics Inc.

Inventors Shao, Liming; Campbell, John Emmerson; Hewitt, Michael Charles; Campbell, Una; Hanania, Taleen G.

Agent HENRY HUGHES LIMITED

Pub. Number AU-A-2010325925

PCT Pub. Number WO2011/069063

Priority 61/266,880 04.12.09 US

Filing date 3 December 2010

Wipo publication date 9 June 2011

International Classifications

C07D 333/56 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 495/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

7 June 2012 PCT application entered the National Phase

  PCT publication WO2011/069063 Priority application(s): WO2011/069063

26 July 2012 Alteration of Name

  The name of the applicant has been altered to Sunovion Pharmaceuticals Inc.; Psychogenics Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010325926-Container and system for decontaminating a medical device with a fog

2010325908-Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema